Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article in Healthline centered around the question of "why don’t people with high deductibles make changes?" As the article explored the question, they cited a study published in The American Journal of Managed Care® (AJMC®). The study, “Impact of Consumer-Directed Health Plans on Low-Value Healthcare,” found that high-deductible health plans encouraged patients to cut healthcare spending indiscriminately instead of cutting low-value services specifically. The AJMC® published study was also highlighted in articles published in Health Exec’s, Becker’s Hospital Review’s, and Twin Cities Business’s articles on how unnecessary medical spending does not decrease with high-deductible plans. The authors of the study concluded that consumer-directed health plans in their current form may represent too blunt an instrument to specifically curtail low-value healthcare spending.
The National Pharmaceutical Council’s CER Daily Newsfeed on Wednesday mentioned an article published on AJMC.com. “Survey: Disconnect in Perceptions of Healthcare Experience Among Stakeholders,” found that there is a significant disconnect between patients, physicians, and employers in their perceived values and priorities in healthcare.
Health Data Management highlighted an AJMC® published study in its article on a health IT tool that aids care for patients with chronic disease: population health coordinators. The study, “Chronic Disease Outcomes From Primary Care Population Health Program Implementation,” found that the use of central population health coordinators led to greater improvement in short-term chronic disease outcome measures compared with patients in practices not assigned a central program health coordinator. The study was also mentioned by Medical Xpress in its article on centralized population health coordinators improving care for patients with chronic disease. The study authors concluded that a population health management program using a health IT tool improved process and outcome measures for patients with diabetes, cardiovascular disease, and hypertension.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More